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Fig. S1
. Age-dependent NGF and TrkA deficits in the HF and CTX of TgCRND8 mice. The levels of (A) NGF mRNA and (B) NGF protein were unaltered in the cholinergic terminal regions of the hippocampus (HF) and cortex (CTX) from 4 to 8 months of age in TgCRND8 and non-Tg mice. Consistent with NGF receptor translation in the cell soma and subsequent protein transport to axonal terminals, (C) TrkA mRNA expression was unchanged in the HF and CTX at all ages examined, whereas (D) TrkA protein and (E) pTrkA levels were decreased in the HF and CTX of 6-month-old and 8-month-old TgCRND8 mice compared to age-matched Non-Tg mice. No change in the levels of (F) p75 NTR mRNA, and (G) p75 NTR protein were observed in TgCRND8 relative to non-Tg littermates from 4 to 8 months of age. (H) There was a decrease in the relative level of TrkA to p75 NTR protein in the HF and CTX of 6-month-old and 8-month-old TgCRND8 mice compared to non-Tg controls. All mRNA levels were measured by qRT-PCR. NGF protein was analyzed by ELISA. TrkA and p75 NTR protein were quantified by Western blot. Statistics: Repeated measures 2-way ANOVA. Significance: * p < 0.05; ** p < 0.01; *** p < 0.001 compared to age-matched, non-Tg mice. Data represent the mean ± SEM; n = 8 per group. and NBM after injection of D3 or PBS and untreated non-Tg mice. Blots were probed for pTrkA, pAkt, pMAPK, pCREB, pJNK, and the corresponding total proteins, then reprobed for βtubIII to control for loading. Using densitometric analysis, D3-treated mice demonstrated (B) increased levels of pTrkA, (C) pAkt, (D) pMAPK, and (E) pCREB relative to untreated and PBS-injected mice. (F) pJNK levels remained stable after D3 injection relative to controls. All phosphorylation signal intensity values were normalized to the respective total protein levels. Densitometric analysis revealed no changes in (G) Akt, (H) MAPK, (I) CREB, and (J) JNK total protein levels normalized to βtubIII among all conditions examined. Statistics: 1-way ANOVA. Significance: *p < 0.05, **p < 0.01 compared with untreated mice. Data represent the mean + SEM; n = 4 per group. Blots were probed for pTrkA, pAkt, pMAPK, pCREB, pJNK, and the corresponding total proteins, then reprobed for βtubIII to control for loading. Using densitometric analysis, NGF-treated mice showed (B) increased levels of pTrkA, (C) pAkt, (D) pMAPK, and (E) pCREB relative to PBS-injected mice. (F) pJNK levels remained unchanged in NGF-treated relative to PBS-treated animals. All phosphorylation signal intensity values were normalized to the respective total protein levels. Densitometric analysis revealed no changes in (G) Akt, (H) MAPK, (I) CREB, and (J) JNK total protein levels normalized to βtubIII in NGF relative to PBS-injected mice. Statistics: Student t-test. Significance: *p < 0.05, **p < 0.01 compared with PBS-treated mice. Data represent the mean + SEM; n = 4 per group. 
